[Tumor necrosis factor].
Herrmann
F
F
Abteilung für Hämatologie, 1. Medizinische Klinik und Poliklinik der Universität Mainz.
Mertelsmann
R
R
D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D011994:Recombinant Proteins / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000009:adverse effects / Q000235:genetics / Q000494:pharmacology / Q000627:therapeutic use*
D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha
Tumornekrosefaktor.